Venture Life Group Plc VLG
The previous Venture Life Group Plc dividend was 0.04p and it went ex almost 4 years ago and it was paid almost 4 years ago.
There is typically 1 dividend per year (excluding specials).
|Summary||Previous dividend||Next dividend|
|Declaration date||22 Mar 2018 (Thu)||–|
|Ex-div date||24 May 2018 (Thu)||–|
|Pay date||22 Jun 2018 (Fri)||–|
Enter the number of Venture Life Group Plc shares you hold and we'll calculate your dividend payments:
Sign up for Venture Life Group Plc and we'll email you the dividend information when they declare.
Add Venture Life Group Plc to receive free notifications when they declare their dividends.
Your account is set up to receive Venture Life Group Plc notifications.
|Status||Type||Decl. date||Ex-div date||Pay date||Decl. Currency||Forecast amount||Decl. amount||Accuracy|
|Paid||Final||22 Mar 2018||24 May 2018||22 Jun 2018||GBP||—||0.04p|
|Paid||Final||23 Mar 2017||25 May 2017||23 Jun 2017||GBP||—||0.04p|
|Paid||Final||04 May 2016||26 May 2016||24 Jun 2016||GBP||—||0.04p|
|Paid||Final||25 Mar 2015||21 May 2015||19 Jun 2015||GBP||—||0.04p|
|Paid||Final||05 Jun 2014||11 Jun 2014||15 Jul 2014||GBP||—||0.04p|
Venture Life Group Plc Optimized Dividend Chart
About Venture Life Group Plc
Venture Life Group plc is a United Kingdom-based consumer self-care company. The Company is focused on developing, manufacturing and commercializing products for the global self-care market. The Company's segments include Brands, which includes sales of healthcare and skin care products under distribution agreements and direct to United Kingdom retailers, and Development and Manufacturing. Through its two Development and Manufacturing operations in Italy and Sweden, the Company also provides development and manufacturing services to companies in the medical devices and cosmetic sectors. Its product portfolio includes the UltraDEX and Dentyl oral care product ranges, the Balance Active range in the area of women's intimate healthcare, the Lift and Glucogel product ranges for hypoglycaemia, Gelclair and Pomi-T for oncology support, products for fungal infections and proctology, and dermo-cosmetics for addressing the signs of ageing.
- Pharmaceuticals & Biotechnology
- United Kingdom
- Share Price
- £0.33 (yesterday's closing price)
- Shares in Issue
- 126 million
- Market Cap
- Market Indices